Dr Reddy's Laboratories sued over cancer drug patent
23 September 2013 | News | By BioSpectrum Bureau
Dr Reddy's Laboratories sued over cancer drug patent
Patent wars
In its petition, Genzyme alleged that Dr Reddy's had intimated through a letter that it had submitted an Abbreviated New Drug Application (ANDA) with the US FDA for approval to engage in the commercial manufacture, importation, use and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil.
